Healthcare providers, payers, drug and device manufacturers, clinical labs and other stakeholders in the healthcare industry will play an important and significant role in the response to COVID-19. Hospitals and providers are addressing critical issues posed by the current outbreak, and must be prepared with robust emergency and disaster recovery plans, access to critical care for impacted patients, accommodations for potential supply chain disruptions, and other systemic risks to the provision of care to patients by an overwhelmed healthcare system.
Payers will face their own challenges related to access to care and coverage decisions regarding diagnosis and treatment, including the reimbursement for new drugs for treatment and vaccination. Additionally, drug manufacturers are working alongside hospitals, research organizations and the government to develop both a vaccine for COVID-19 and possible antiviral medications to help mitigate the impact on infected patients, while labs are developing necessary tests. Our Healthcare & Life Sciences Industry Sector Group is available to help with any of these issues and advise you on the key impacts to your businesses.
Holland & Knight’s multidisciplinary COVID-19 Response Team is available to help clients respond to a variety of business and legal issues they may be facing.
Additional COVID-19 Resources for your Business
Workforce & Employment and Immigration | Healthcare & Life Sciences | Transportation & Infrastructure | Bankruptcy and Creditors' Rights | Contracts | Public Companies | Government Contracting | Hospitality | Financial Services and Finance | Real Estate | Privacy & Cybersecurity | Energy, Natural Resources and Environmental | Federal Government Funding Opportunities | State and Local COVID-19 Activities | Insurance/Risk Guidance | Latin America | Remote Online Notarizations & Digital Signatures | Enforcement | Israel
Please note that email communications to the firm through this website do not create an attorney-client relationship between you and the firm. Do not send any privileged or confidential information to the firm through this website. Click "accept" below to confirm that you have read and understand this notice.